CORCEPT THERAPEUTICS INC — Director's Dealing 2017

Feb 28, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2017-02-23

Reporting Person: ENRIGHT PATRICK G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-23	Common Stock	S	1470525	$8.65	Disposed	9270195	Indirect
2017-02-23	Common Stock	S	29475	$8.65	Disposed	185807	Indirect
2017-02-27	Common Stock	S	980350	$9.05	Disposed	8289845	Indirect
2017-02-27	Common Stock	S	19650	$9.05	Disposed	166157	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	204210	Direct

Footnotes

F1: Reflects shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP") and Longitude Capital Partners, L.P. ("LCA"). Mr. Enright is a managing member of Longitude Capital Partners, LLC, the sole general partner of LVP and LCA. Mr. Enright disclaims beneficial ownership of the securities of the Issuer held of record by LVP and LCA, except to the extent of his pecuniary interest therein.